Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 2/20 | 0.48 |
| ▸ | LAP3 | P28838 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL354949 | 1.00 | SLC15A1 (0.61) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL2137609 | 1.00 | SLC15A1 (0.61) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL2135391 | 0.98 | SLC15A1 (0.59) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL7275901 | 0.98 | SLC15A1 (0.59) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL542587 | 0.98 | SLC15A1 (0.59) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL2137602 | 0.98 | SLC15A1 (0.59) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL7275897 | 0.98 | SLC15A1 (0.59) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| Valine SCHEMBL28244846 | 0.95 | SLC15A1 (0.60) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| Valine SCHEMBL28244847 | 0.95 | SLC15A1 (0.60) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| Lactic Acid SCHEMBL28307486 | 0.94 | SLC15A1 (0.59) | SLC15A1ALDH1A1SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112812149-B | Amino acid derivative, preparation method and application thereof, anti-tumor micelle and preparation method thereof | 首都医科大学 | 2022-04-29 | — | — | CN | claimed |
| CN-107698660-B | imidazopyridine-6-formyl-Lys (Lys) -oligopeptides, their synthesis, activity and uses | 首都医科大学 | 2021-06-08 | — | — | CN | claimed |
| CN-106349332-B | imidazopyridinyl-KRGDV, its synthesis, antithrombotic activity and use | 首都医科大学 | 2019-12-10 | — | — | CN | claimed |
| CN-107698660-A | Imidazopyridine -6- formyls-Lys (Lys)-oligopeptides, it is synthesized, activity and application | 首都医科大学 | 2018-02-16 | — | — | CN | claimed |
| CN-107033215-A | Imidazopyridine acyl-KAGDV, it is synthesized, antithrombotic acitivity and application | 首都医科大学 | 2017-08-11 | — | — | CN | claimed |
| CN-106349332-A | Imidazo pyridine acyl-KRGDV, synthesis thereof, antithrombus activity and application | 首都医科大学 | 2017-01-25 | — | — | CN | claimed |
| CN-103159827-B | (1R, 3S)-1-p-nitrophenyl-tetrahydro-beta-carboline amic acid, its synthesis, anti-thrombus activity and application | Capital Medical University (CN) | 2016-03-30 | — | — | CN | claimed |
| CN-103159758-B | (1S, 3S)-1-p-nitrophenyl-1,2,3,4-tetrahydro-beta-carboline amic acid, its synthesis, anti-thrombus activity and the application as antithrombotic agent | Capital Medical University (CN) | 2015-08-05 | — | — | CN | claimed |
| CN-103554047-A | Method for preparing valsartan | ZHENJIANG COLLEGE | 2014-02-05 | — | — | CN | claimed |
| CN-102241675-B | (1R,3S)-1-(4-hydroxyl-3-methoxycarboxyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl amino acid derivatives as well as preparation method and application thereof | UNIV CAPITAL MEDICAL | 2013-06-19 | — | — | CN | claimed |
| CN-103159827-A | Synthesis, anti-thrombotic activity, and application of (1R, 3S) -1-p-nitrophenyl-1,2,3,4-tetrahydro-beta-carboline acyl amino acid | UNIV CAPITAL MEDICAL | 2013-06-19 | — | — | CN | claimed |
| CN-103159758-A | (1S,3S)-1-p-nitrophenyl-1,2,3,4-tetrahydro-beta-carboline acyl amino acid, and synthesis, antithrombotic activity and application as antithrombotic agent thereof | UNIV CAPITAL MEDICAL | 2013-06-19 | — | — | CN | claimed |
| EP-2152678-A1 | PROCESS FOR PREPARING VALSARTAN | Cipla Limited (IN) | 2010-02-17 | — | — | EP | claimed |
| WO-2008135762-A1 | PROCESS FOR PREPARING VALSARTAN | CIPLA LIMITED (IN) | 2008-11-13 | — | — | WO | claimed |
| WO-2008012852-A1 | INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF ANGIOTENSIN II ANTAGONISTS | S.I.M.S. S.r.l. - SOCIETÀ ITALIANA MEDICINALI SCANDICCI (IT) | 2008-01-31 | — | — | WO | claimed |
| US-5602161-A | ELASTASE INHIBITORS; PREVENTING AND TREATING EMPHYSEMA, ENDOTOXIN-INDUCED LUNG DISORDERS | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 1997-02-11 | — | — | US | claimed |
| EP-0676396-A1 | Tetrazolylphenyl pivalate derivatives and medicinal composition containing the same as effective component | Wakamoto Pharmaceutical Co., Ltd. (JP) | 1995-10-11 | — | — | EP | claimed |
| CN-116617403-B | Amino acid modified ionic liquid and preparation method and application thereof | 北京大学 | 2026-05-19 | — | — | CN | disclosed |
| EP-0268343-A2 | Enzymatic process for 3-substituted cephalosporins | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (GB) | 1988-05-25 | — | — | EP | disclosed |
| US-4000139-A | ERGOT ALKALOID INTERMEDIATES | SANDOZ LTD. (CH) | 1976-12-28 | — | — | US | disclosed |